
Sorrento Therapeutics SRNE
Quartalsbericht 2023-Q2
hinzugefügt 16.05.2026
Sorrento Therapeutics ROE 2011-2026 | SRNE
ROE Jährlich Sorrento Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3078.97 | -543.92 | -180.72 | -371.64 | -97.17 | 4.58 | -76.12 | -31.56 | -31.88 | -32.8 | -78.18 | -76.89 | -35.57 | -29.44 | 21.92 | 17.78 | 100.53 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3078.97 | -543.92 | 96.35 |
ROE Vierteljährlich Sorrento Therapeutics
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -75.97 | -140.4 | -251.65 | -435.04 | -458.21 | -382.01 | -362.91 | -222.81 | -172.61 | -139.74 | -205.34 | -241.98 | -341.44 | -352.77 | -370.15 | -313.98 | -194.98 | -156.07 | -88.03 | -39.99 | -20.81 | -7.12 | -33.16 | -79.75 | -59.54 | -75.79 | -55.27 | -51.28 | -69.96 | -50.37 | -41.41 | -30.91 | -40.98 | -39.81 | -46.43 | -49.48 | -120.86 | -134.46 | -117.4 | -134.29 | -134.51 | -79.03 | -54.6 | -79.34 | -93.78 | -98.95 | -72.34 | -24.74 | -31.34 | -16.26 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -7.12 | -458.21 | -137.8 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-528.29 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-32.54 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
21.0 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
30.52 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
3750.6 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-55.98 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-948.23 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-69.02 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
-152.74 | - | - | $ 344 M | ||
|
IMV
IMV
|
575.45 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
-5.91 | $ 91.4 | 1.15 % | $ 22.1 B | ||
|
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.66 | 2.21 % | $ 442 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
43.82 | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
34.4 | $ 2.65 | -2.22 % | $ 248 M | ||
|
Anika Therapeutics
ANIK
|
-7.58 | $ 15.09 | -0.33 % | $ 216 M | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.4 | 2.41 % | $ 5.6 M | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
275.39 | $ 1.6 | 5.63 % | $ 187 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-146.95 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 20.95 | 2.34 % | $ 2.67 B | ||
|
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-294.78 | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
698.49 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
125.33 | - | 17.91 % | $ 11.1 M |